BRIEF

on Tribun Health (EPA:GIB.A)

Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions

PARIS, FRANCE AND MONTREAL, QUEBEC / ACCESSWIRE / August 28, 2024 / Tribun Health, a leader in digital pathology solutions, has announced a strategic partnership with Ibex Medical Analytics. This collaboration will integrate Ibex's AI-powered diagnostic tools into Tribun Health's CaloPix® Information Management System (IMS), enhancing healthcare providers' diagnostic capabilities globally.

Under the agreement, Tribun Health will include Ibex's products for prostate, breast, and gastric tissues in the CaloPix® IMS. These AI solutions use deep learning algorithms to improve cancer detection and diagnosis accuracy.

The integration will allow pathologists to use Ibex's diagnostic tools within their clinical workflows. Cases will automatically be analyzed by Ibex's AI, with results available in CaloPix® for intelligent case triage and slide review, addressing the growing demand for AI-driven diagnostic solutions.

The collaboration highlights the commitment of both companies to enhance patient care through innovative AI technology. It marks significant progress in AI adoption in healthcare, aiming to improve cancer diagnostics in Canada, the EU, and the US.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Tribun Health news